Coherus Oncology, Inc. (CHRS)
NASDAQ·Healthcare·Biotechnology
$0.80
+3.73%
Mkt Cap $131.36M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$6.02
Range $1.05 – $11.00
Implied Upside
+657.2%
Consensus $6.02 vs current $0.80
NASDAQ·Healthcare·Biotechnology
$0.80
+3.73%
Mkt Cap $131.36M
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$6.02
Range $1.05 – $11.00
+657.2%
Consensus $6.02 vs current $0.80